This is a patient-reported outcome performance measure (PRO-PM) consisting of a patient-reported outcome measure (PROM) of risk-adjusted functional status (FS) change in balance confidence for patients aged 14+ with balance impairments. The change in FS is assessed using the FOTO Balance Confidence, an item-response theory-based PROM derived from the 16-items of the Activities-specific Balance Confidence (ABC) Scale©, (1-3) scored using the T-score metric (mean=50, SD=10), with higher scores representing higher balance confidence.(4)
Patient responses to ABC Scale© items may be used to directly score Balance Confidence PROM, thus allowing clinicians flexibility of choice of PROM used in routine clinical care without adding to patient response burden. In order to fairly measure performance between providers, this quality measure is risk-adjusted to patient characteristics known to be associated with FS outcomes and used as a performance measure the patient and provider levels to assess quality.
Percentage of final pathology reports for excisions for squamous cell carcinoma of the skin that include a comment on margin status, degree of differentiation/histologic grade, depth or level of invasion, presence of perineural invasion* and presence of lymphovascular invasion
*Perineural invasion defined as tumor cells within the nerve sheath of a nerve deep to the dermis or with a caliber of 0.1 mm or higher.
Percentage of esophageal biopsy reports with a diagnosis of Barrett’s esophagus that include documentation of a consultation* with a second pathologist for confirmation of dysplasia grading.
*Consultation at the time of diagnosis or addendum to preliminary pathology report
Percentage of pathology reports for gastric specimens with intestinal metaplasia that comment on the presence or absence of H. pylori and of dysplasia. If dysplasia is present, comment on the grade of dysplasia. If dysplasia is not present, comment on completeness of intestinal metaplasia.
Percentage of pathology reports for endometrial carcinoma that comment on POLE and p53 testing status, and status of IHC for PMS2 and MSH6.
Percentage of Patients with Low Back Pain and/or Migraines Who Were Not Prescribed an Opiate
Percentage of Opioid Poisoning or Overdose Patients Presenting to An Acute Care Facility Who Were Prescribed Naloxone at Discharge
Percentage of urinary bladder carcinoma pathology reports that include the procedure, histologic tumor grade, histologic type, presence/absence of muscularis propria, presence/absence of lymphovascular invasion, and tumor extent.
AND
meet the maximum 2 business day turnaround time (TAT) requirement (Report Date – Accession Date is less than or equal to 2 business days).
INSTRUCTIONS: This measure has two performance rates that contribute to the overall performance score:
Stratum 1. Percent of cases for which all required data elements of the urinary bladder carcinoma pathology report are included.
Stratum 2. Percent of cases that meet the maximum 2 business day turnaround time.
The overall performance score submitted is a weighted average of:
(Performance rate 1 x 70%)+(Performance rate 2 x 30%)
Percentage of non-small cell lung cancer (NSCLC) pathology reports that include anaplastic lymphoma kinase (ALK), epidermal growth factor receptor (EGFR), AND tyrosine protein kinase ROS1 mutation status.
